Aliquots were thawed and 500 μL of serum was diluted to a final volume containing 50% (v/v) serum, 40% (v/v) dd 1H2O (18.2 MΩ), 10% (v/v) 1 M PO43− pH 7.4 buffer (Na2HPO4, VWR International Ltd., Radnor, PA, USA and NaH2PO4, Sigma-Aldrich, Gillingham, UK) in deuterium oxide (2H2O, Sigma-Aldrich) and 1.2 mM sodium azide (NaN3, Sigma-Aldrich). Samples were vortexed for 1 min, centrifuged at 13,000× g at 4 °C for 2 min and 600 μL transferred into 5 mm outer diameter NMR tubes (Bruker, Coventry, UK).
Urine & saliva samples were thawed at room temperature before addition of 500 μL to 500 μL of 1 M phosphate buffer (Na2HPO4 and NaH2PO4) at pH7.4 with 20% 2H2O, 200 μM TSP and 2.4 mM sodium azide. The samples were vortexed for 30 s prior to 5 min centrifugation at 21,500× g and 4 °C before transferring 600 μL of sample to Bruker SampleJet 5 mm (outer diameter) NMR tubes. The final concentration in the NMR tube was 50% urine or saliva, 10% 2H2O, 1.2 mM sodium azide and 100 μM TSP.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.